Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Red Blood Cell - IMProving trAnsfusions for Chronically Transfused Recipients (RBC-IMPACT)

NCT05255445 is registered in ClinicalTrials.gov with Westat as lead sponsor.

NCT NCT05255445
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05255445 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Red Blood Cell - IMProving trAnsfusions for Chronically Transfused Recipients (RBC-IMPACT)
Lead sponsor
Westat
Phase
Observational
Overall status
Completed
Start date
March 16, 2022
Completion date
March 31, 2024
Enrollment
157 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

pediatric cancer, sickle cell disease, thalassemia